The study did not include physicians or nurse practitioners as participants despite recruitment attempts
People with diabetes, particularly severe diabetes, tend to lose less weight with GLP-1s than people without diabetes, so microdosing is less likely to be as effective, though their dose should only be increased as they tolerate it. George said that in her professional opinion, microdosing is a potential option for patients with smaller amounts of weight to lose or as a bridge to start, or wean off, regular GLP-1 medications
With eczema, the barrier of your skin is damaged, and youre losing moisture, says Katie Rodan, MD, a dermatologist and cofounder of Rodan + Fields, based in Oakland, California
Historically, scientists thought GIP might actually cause weight gain (because it helps store energy)